Xiaodong He

4.3k total citations
225 papers, 2.8k citations indexed

About

Xiaodong He is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Xiaodong He has authored 225 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Surgery, 59 papers in Molecular Biology and 55 papers in Oncology. Recurrent topics in Xiaodong He's work include Cholangiocarcinoma and Gallbladder Cancer Studies (29 papers), Gallbladder and Bile Duct Disorders (21 papers) and Cancer-related molecular mechanisms research (18 papers). Xiaodong He is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (29 papers), Gallbladder and Bile Duct Disorders (21 papers) and Cancer-related molecular mechanisms research (18 papers). Xiaodong He collaborates with scholars based in China, United States and Japan. Xiaodong He's co-authors include Qiang Qu, Lianyuan Tao, Chaoji Zheng, Binglu Li, Tao Hong, Xin Wu, Lei Cai, Peng‐Hui Wang, Li Zhou and Jing‐An Rui and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Xiaodong He

203 papers receiving 2.8k citations

Peers

Xiaodong He
Comparison fields: 5 of 142
  • Molecular Biology 1.0k
  • Surgery 752
  • Oncology 660
  • Cancer Research 600
  • Pulmonary and Respiratory Medicine 516
Keiichi Ito Japan
Xin Zhang China
Gregory Kouraklis Greece
Lei Feng China
Takashi Kobayashi Japan
Balraj Mittal India
Jie Cai China
Liping Du China
Rolf‐Edgar Silber Germany
Keiichi Ito Japan View profile →
Citations per field, relative to Xiaodong He
Xiaodong He · 1×
Citations per year, relative to Xiaodong He
Xiaodong He · 1×

Countries citing papers authored by Xiaodong He

Since Specialization
Citations

This map shows the geographic impact of Xiaodong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong He more than expected).

Fields of papers citing papers by Xiaodong He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong He. The network helps show where Xiaodong He may publish in the future.

Co-authorship network of co-authors of Xiaodong He

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodong He. A scholar is included among the top collaborators of Xiaodong He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodong He. Xiaodong He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 0
3 2
4 0
5 1
6 0
7 1
8 2
9 4
10 2
11 4
12 9
13 6
14 3
15 4
16 4
17 0
18 27
19 2
20 22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026